IMBdx

461030· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

₩3,205+5.78%

2026-08-04

Financials

Valuation Metrics

IMBdx's Market Cap is ₩459B. At end of 2025 it was ₩1418B. Ranked #1797 of 2,436 in KR market (top 74%), #1097 of 1,649 on KOSDAQ (top 67%), #198 of 234 in Pharmaceuticals, Biotechnology & Life Sciences (top 85%) by Market Cap.

Investment Metrics(as of 2026-08-04)

Metric	Value	Rank
Size
Market Cap	45.94B KRW	KR#1,797/2,436 Sec#198/234
Revenue	5.60B KRW	KR#2,338/2,436 Sec#193/234
Net Income	-8.41B KRW	KR—/2,436 Sec—/234
Total Assets	26.46B KRW	KR#2,343/2,436 Sec#225/234
Net Assets	24.38B KRW	KR#2,223/2,436 Sec#205/234
Value
P/B	1.88x	KR#1,914/2,436 Sec#140/234
P/S	8.20x	KR#2,245/2,436 Sec#155/234
FCF Yield	-15.30%	KR—/2,436 Sec—/234
Profitability
ROE	-34.49%	KR#2,200/2,436 Sec#181/234
ROA	-31.78%	KR#2,312/2,436 Sec#204/234
Op. Margin	-162.77%	KR#2,334/2,436 Sec#184/234
Revenue Growth	27.06%	KR#523/2,436 Sec#51/234
Financial Health
Debt Ratio	108.54%	KR#408/2,436 Sec#58/234
Total Debt	0 KRW	KR—/2,436 Sec—/234
FCF	-7.03B KRW	KR#1,597/2,436 Sec#131/234
Cash	2.00B KRW	KR#2,245/2,436 Sec#215/234
Current Ratio	15.87x	KR#43/2,436 Sec#15/234
Performance
1Y Return	-57.38%	KR#2,201/2,436 Sec#206/234
1M Return	-8.69%	KR#1,684/2,436 Sec#169/234
From 52W High	-75.33%	KR#2,285/2,436 Sec#213/234
1Y MDD	-78.52%	KR#2,259/2,436 Sec#205/234
Trading
Volume	17,367 shares	KR#1,914/2,436 Sec#190/234
Foreign Own.	5.46%	KR—/2,436 Sec—/234
Per Share
EPS	-598 KRW	KR—/2,436 Sec—/234
BPS	1,700 KRW	KR#2,113/2,436 Sec#179/234